Gilead Sciences Inc (NASDAQ:GILD)
| 79.59 Delayed Data As of 4:00pm ET |  -0.41 / -0.51%Today’s Change | 57.17 Today|||52-Week Range 89.74 | -7.29% Year-to-Date |
Latest GILD News | Press Releases
Today’s Trading
| Previous close | 80.00 |
| Today’s open | 80.34 |
| Day’s range | 79.46 - 80.98 |
| Volume | 135,469 |
| Average volume (3 months) | 6,747,112 |
| Market cap | $99.9B |
Data as of 4:00pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | -26.17% |
| Earnings growth (this year) | -5.73% |
| Earnings growth (next 5 years) | +1.05% |
| Revenue growth (last year) | -1.05% |
| P/E ratio | 21.9 |
| Price/Sales | 4.00 |
| Price/Book | 4.70 |
Competitors
Data as of 4:00pm ET, 03/27/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | $1.55 |
| Annual revenue (last year) | $27.1B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 16.95% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
